Global private equity and venture capital news and research

US biopharma Aerpio Therapeutics clinches $27m Series A

30 Aug 2012

blood_vein_170sqClinical‐stage biopharmaceutical company Aerpio Therapeutics has closed a $27m Series A financing led by life sciences investor Novartis BioVentures and joined by Venture Investors, Triathlon Medical Ventures, Kearny Venture Partners, Athenian Venture Partners and AgeChem Venture Fund.

Sorry, to get access to this you need to subscribe for free.

In order to view more content, sign-up to our free daily newsletter.

If you would like to read the premium stories, have complete access to our breaking news and Limited Partner magazine you need to become a Premium Subscriber.

Subscribe to AltAssets today

Login to AltAssets

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016